These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2363276)

  • 1. [Immunization of rabbits with Lassa virus].
    Orlova SV; Godneva AT; Ignat'ev GM; Bystrova SI
    Vopr Virusol; 1990; 35(1):59-61. PubMed ID: 2363276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of the immune response in mice immunized with the inactivated Lassa virus].
    Ignat'ev GM; Golubev VP; Godneva AT; Petkevich AS; Torop AV
    Vopr Virusol; 1989; 34(2):213-6. PubMed ID: 2474905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of storage temperature on the stability of Lassa virus complement-fixing antigen.
    Tomori O
    Bull World Health Organ; 1980; 58(2):293-6. PubMed ID: 6772319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The indirect hemagglutination reaction for the detection of the Lassa virus].
    Vladyko AS; Kramarenko LP; Cherednichenko IA; Surikova LE
    Vopr Virusol; 1988; 33(4):498-502. PubMed ID: 3195147
    [No Abstract]   [Full Text] [Related]  

  • 5. [The dynamics of the formation of IgG subclasses in Balb/c and CBA mice infected with the LCM, Lassa and Mopeia viruses and their role in diagnosis].
    Zaĭtseva VN; Bystrova SI; Shkolina TV; Vladyko AS
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (1):47-51. PubMed ID: 9221657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of monoclonal antibodies against Lassa virus].
    Vladyko AS; Bystrova SI; Lemeshko NN; Lukashevich IS
    Mol Gen Mikrobiol Virusol; 1987 May; (5):37-40. PubMed ID: 2441254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin.
    Jahrling PB
    J Med Virol; 1983; 12(2):93-102. PubMed ID: 6619814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dynamics of antigen and antibody accumulation in adult mice, infected with Lassa virus].
    Vladyko AS; Surikova LE; Kramarenko LP; Bystrova SI; Torop AV
    Vopr Virusol; 1989; 34(1):100-3. PubMed ID: 2658319
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of betapropionolactone inactivated Ebola, Marburg and Lassa intracellular antigens in immunofluorescent antibody assay.
    Van der Groen G; Elliot LH
    Ann Soc Belg Med Trop; 1982 Mar; 62(1):49-54. PubMed ID: 7049096
    [No Abstract]   [Full Text] [Related]  

  • 10. Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain.
    Jahrling PB; Peters CJ
    Infect Immun; 1984 May; 44(2):528-33. PubMed ID: 6715049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to Lassa and Lassa-like viruses in man and mammals in the Central African Republic.
    Georges AJ; Gonzalez JP; Abdul-Wahid S; Saluzzo JF; Meunier DM; McCormick JB
    Trans R Soc Trop Med Hyg; 1985; 79(1):78-9. PubMed ID: 2986324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever.
    Clegg JC; Lloyd G
    Lancet; 1987 Jul; 2(8552):186-8. PubMed ID: 2885642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of the accumulation of the Lassa virus in Vero cells by immune gamma globulin and complement].
    Vladyko AS; Rogacheva TA; Orlova SV; Votiakov VI
    Vopr Virusol; 1984; 29(4):473-6. PubMed ID: 6208692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies.
    Hufert FT; Lüdke W; Schmitz H
    Arch Virol; 1989; 106(3-4):201-12. PubMed ID: 2476109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lassa fever virus in Senegal.
    Saluzzo JF; Adam F; McCormick JB; Digoutte JP
    J Infect Dis; 1988 Mar; 157(3):605. PubMed ID: 3343533
    [No Abstract]   [Full Text] [Related]  

  • 16. Lassa fever antibodies in hospital personnel in the Plateau State of Nigeria.
    Fabiyi A; Tomori O; Pinneo P
    Niger Med J; 1979 Jan; 9(1):23-5. PubMed ID: 463337
    [No Abstract]   [Full Text] [Related]  

  • 17. [The localization and preliminary characteristics of antigenic sites (B epitopes) in the nucleocapsid protein of the Lassa virus].
    Vladyko AS; Bystrova SI; Malakhova IV; Kunitskaia LIa; Lemeshko NN; Kras'ko AG; Kozhich AT; Lukashevich IS
    Vopr Virusol; 1993; 38(1):30-4. PubMed ID: 7521097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein.
    Rodriguez-Carreno MP; Nelson MS; Botten J; Smith-Nixon K; Buchmeier MJ; Whitton JL
    Virology; 2005 Apr; 335(1):87-98. PubMed ID: 15823608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The immunogenic activity of the Lassa virus structural proteins].
    Bystrova SI; Lemeshko NN; Shkolina TV; Vladyko AS
    Vopr Virusol; 1992; 37(1):56-8. PubMed ID: 1384241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible approaches to a vaccine against Lassa fever.
    Clegg JC
    Trans R Soc Trop Med Hyg; 1984; 78(3):307-10. PubMed ID: 6464128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.